Induction of the Myc-oestrogen receptor fusion protein (MycER) by 4-OH-tamoxifen (OHT) leads to the activation of Cyclin E/Cyclin-dependent kinase 2 (CycE/Cdk2) complexes followed by the induction of DNA synthesis. As CycE/Cdk2 activity is essential for G1/S transition, we have investigated the mechanism by which Myc can activiate CycE/Cdk2. Our results suggest that this activation may involve at least two Myc-dependent steps: the induction of cyclin E gene transcription followed by accumulation of cyclin E mRNA in a protein synthesis-independent manner and the inhibition of p27
Introduction
The proto-oncogene c-myc is a key regulator of cell proliferation and apoptosis (reviewed in Amati and Land, 1994; Henriksson and LuÈ scher, 1996; Marcu et al., 1992) . c-myc encodes a basic ± helix ± loop ± helix ± leucine zipper transcription factor (Myc) that dimerises with Max (Blackwood and Eisenman, 1991; Prendergast et al., 1991) and binds to DNA in a sequencespeci®c manner (Blackwell et al., 1990; Prendergast, et al., 1991) . Myc/Max heterodimers activate transcription (Amati et al., 1992; Kretzner et al., 1992) and are required for Myc-induced cell transformation, cell cycle progression and apoptosis (Amati et al., 1993a; 1993b) .
Myc is rapidly induced by growth factors (reviewed in Kelly and Siebenlist, 1986) and is required for mitogenic signalling by the colony-stimulating factor (CSF) (Roussel et al., 1991) and platelet derived growth factor (PDGF) receptors (Barone and Courtneidge, 1995) . Constitutive expression of Myc prevents exit from the cell cycle as well as dierentiation (Henriksson and LuÈ scher, 1996; Marcu et al., 1992) and induces apoptosis in the absence of survival cytokines Harrington et al., 1994) . Moreover, Myc activity is sucient to drive resting cells into the cell cycle (Eilers et al., 1991) . Although several genes have been identi®ed that are regulated by Myc (Bello-Fernandez et al., 1993; Benvenisty et al., 1992; Galaktionov et al., 1996; Gaubatz et al., 1994; Reisman et al., 1993) , none of these genes has been clearly implicated in Myc-induced progression from the G1 into the S phase of the cell cycle.
G1 progression is controlled by the activities of the cyclin-dependent kinase complexes cyclinD/Cdk4 (or Cdk6) and cyclinE (CycE)/Cdk2 (for reviews see Draetta, 1994; Sherr, 1994) . Cyclins D and E are essential for G1/S progression of higher eukaryotic cells (Baldin et al., 1993; Knoblich et al., 1994; Ohtsubo et al., 1995; Quelle et al., 1993) and when overexpressed are able to shorten the G1 interval (Ohtsubo and Roberts, 1993; Quelle et al., 1993; Resnitzky et al., 1994; Wimmel et al., 1994) indicating that both cyclins are rate-limiting for G1/S transition. Myc-induced G1/S progression involves induction of CycE/Cdk2 activity several hours prior to the activation of cyclin D/Cdk4 complexes (Steiner et al., 1995) . This rapid activation of CycE/Cdk2 in response to Myc suggested a close relationship between Myc function and CycE/Cdk2 activity. Regulation of CycE/ Cdk2 activity occurs at multiple levels involving the synthesis of the subunits, assembly, phosphorylationdephosphorylation and the association of inhibitory proteins such as p21
Cip1 and p27 Kip1 (reviewed in Morgan, 1995; Sherr and Roberts, 1995) . To explore how Myc can induce CycE/Cdk2 activation we set out to identify the earliest Myc-sensitive events in this process.
Results

Myc-induced CycE/Cdk2 activation occurs within a small fraction of complexes
In order to follow the kinetics of Myc-dependent CycE/Cdk2 activation we used Rat1 ®broblasts expressing a regulatable fusion protein between Myc and the hormone-binding domain of the human oestrogen receptor (MycER) (Eilers et al., 1989; Evan et al., 1992; Solomon et al., 1995) . In agreement with Steiner et al. (1995) we found that when MycER was activated by 4OH-tamoxifen (OHT), CycE-dependent kinase activity was rapidly induced. Upon exposure of con¯uent serum-free cultures to OHT for 4 and 8 h we observed 60% and maximal induction of CycEdependent kinase activity, respectively (Figure 1a , bottom panel and data not shown). We also detected a small but reproducible increase in the steady state levels of CycE protein during this induction ( Figure 1a , top panel). Moreover, the cells entered S-phase after 12 h of Myc activation (not shown).
The activity of CycE-dependent kinase complexes can be regulated via the binding of the cell cycle inhibitors p21
Cip1 or p27
Kip1
. Rat1 cells, however, do not express detectable levels of p21 Cip1 (not shown). We therefore investigated the p27
Kip1 levels bound to CycE at various times after Myc activation by immunoblotting following immunoprecipitation with CycE-speci®c antibodies. Although the kinase activity was found to be increased after 4 hr, the amounts of Cdk2 and p27
Kip1 co-precipitated with CycE remained unaltered up to 8 h after Myc activation (Figure 1b) . Thus, either p27
Kip1 is not implicated in the early phase of CycE/ Cdk2 activation, or kinase activation occurs only within a small and in this experiment undetectable fraction of complexes. We therefore wanted to explore the nature of the complexes giving rise to Myc-induced CycE/Cdk2 activity.
First we aimed to determine the proportion of CycE/ Cdk2 complexes that is bound to p27
Kip1 after Myc activation. A p27
Kip1 -speci®c antiserum was used for immunoprecipitation of a lysate derived from MycER cells after 4 h of exposure to OHT. As compared to a control incubated with normal rabbit serum, virtually all of the p27
Kip1 could be depleted from the lysate (Figure 2 , top panel). Subsequent immunoprecipitation of both lysates with a CycE-speci®c antiserum followed by immunoblotting indicated that all CycE-asociated non-CAK-phosphorylated Cdk2 (corresponding to upper band) and about 80% of the faster migrating, CAK-phosphorylated form of Cdk2 (corresponding to lower band (Gu et al., 1992) had been removed by the p27 Nevertheless, the CycE-speci®c kinase activity precipitated by the CycE-speci®c antiserum remained nearly unaected by the depletion of the p27 Kip1 -bound CycE/ Cdk2 complexes (Figure 2, bottom Figure 1a) . Activation of CycE/Cdk2 activity requires Myc to function as a transcription factor (Steiner et al., 1995) . Moreover, cyclin E mRNA levels have been reported to be elevated 10 h after Myc stimulation (Jansen et al., 1993) and to be 50% lower in cells hemizygous for Myc (Hanson et al., 1994) . We therefore examined the expression levels of cyclin E mRNA shortly after Myc activation. Cellular RNA from Rat1 MycER cells was isolated at various times after application of OHT to con¯uent cultures in the absence of serum and analysed by RT ± PCR. We observed a rapid increase in the levels of cyclin E mRNA already 1 h after Myc activation, reaching a three to four-fold induction after approximately 8 h. During this period the levels . Cell lysates were prepared 4 h after OHT stimulation and immunoprecipitated twice with p27
Kip1 antibodies (Depleted) or with normal rabbit serum (Control). The eciency of the depletion was monitored by immunoblotting of p27 Kip1 (top panel). The lysates were then incubated with CycE antibodies and analysed for co-immunoprecipitation of Cdk2 (middle panel) and CycE-dependent kinase activity (bottom panel). The arrows indicate the positions of the bands corresponding to the non-CAK-phosphorylated (upper band) and CAK-phosphorylated (lower band) forms of Cdk2 (Gu et al., 1992) of GAPDH mRNA remain unaltered (Figure 3a and b). Similar results were obtained using additional ampli®cation cycles (not shown), indicating that the DNA ampli®cation had not reached saturation. Nuclear run on analysis performed with nuclei harvested 2.5 h after Myc activation shows that the induction of cyclin E mRNA occurs at least in part at the level of transcription, while GAPDH gene transcription remains unaected. In addition, cyclin A gene transcription is not induced 2.5 h after Myc activation ( Figure 3d ). This is expected, as the Myc-dependent induction of the cyclin A gene requires cyclin-dependent kinase activity (Rudolph et al., 1996) . As shown by Northern analysis, the Myc-induced accumulation of cyclin E mRNA occurs in the presence of various protein synthesis inhibitors (Figure 3e ). Moreover, cyclin E mRNA levels are not altered in response to OHT in the parental Rat1 cells (not shown).
Recently the cdc25A gene encoding a Cdk-speci®c phosphatase was reported to be a direct target of Myc (Galaktionov et al., 1996) . Since Cdc25A can activate CycE/Cdk2 complexes in vitro (Steiner et al., 1995) , we wanted to explore whether cdc25A mRNA was induced by Myc in our cell system. We therefore carried out a similar experiment as described above for cyclin E mRNA and determined the levels of cdc25A mRNA in the same RNA samples. Our results show that there is a mild induction of cdc25A mRNA in response to Myc which in comparison to the response of cyclin E mRNA is slow and only becomes signi®cant after 8 h (Figure 3a and b). Importantly however, there is no signi®cant induction of cdc25A mRNA after 4 h, when CycE/Cdk2 kinase has already become active. Thus, although we cannot rule out some eect of Cdc25A on CycE/Cdk2 activity, it seems unlikely that the regulation of cdc25A mRNA by Myc plays a major role in the early Myc-dependent activation of the kinase. In addition, we did not detect any alteration in the cellular Cdc25A protein levels following Myc activation ( Figure 3c ).
Myc decreases p27
Kip1 binding to CycE/Cdk2 complexes containing newly synthesised CycE
In order to test the role of cyclin E gene transcription in kinase activation we constructed Rat1-derived cell lines in which the synthesis of the human Cyclin E (hCycE) protein is inducible. For this purpose we used a regulatable system (Braselmann et al., 1993) comprising the oestrogen-dependent transactivator (GalER-VP16 and a human cyclin E cDNA under the control of a promoter containing Gal4 DNA binding sites. Rat1 cells infected with a retrovirus containing GalER-VP16 were transfected with the Ga14-dependent hCycE expression plasmid. Several cell clones showing OHT-dependent induction of hCycE as detected by an antibody speci®c for hCycE were isolated. Induction of hCycE was found to be rapid and could be readily detected after 4 h with equilibrium being reached after approximately 8 h. Clone E6 is shown as a representative example ( Figure  4a ). Using the hCycE-speci®c antibody no kinase activity can be observed in absence of hCycE, con®rming the speci®city of the antibody (Figure 4a and b). Induction of hCycE in serum-free medium is not sucient to induce kinase activity (Figure 4b ; see also Ohtsubo et al., 1995; Resnitzky and Reed, 1995) , although over a 16 h period the degree of CAKphosphorylation of hCycE-associated Cdk2 increased to similar levels as seen with the endogenous rat CycE (compare Figures 4c and 1b) . Nevertheless, the transfected hCycE protein is functional as in the presence of serum it becomes associated with active kinase complexes (Figure 4b ; see also Ohtsubo et al., 1995; Resnitzky and Reed, 1995) . Although the stimulation of CycE synthesis is not sucient to induce CycE/Cdk2 activity, the Mycinduced increase in CycE synthesis may play a role in the activation of CycE/Cdk2 by boosting the fraction of activatable complexes. We therefore examined the fate of CycE/Cdk2 complexes containing newly synthesised CycE molecules in the presence and absence of active Myc. The GalER-dependent hCycE expression in Rat1 cells permitted us to perform such experiments, since following OHT induction we were able to speci®cally immunoprecipitate hCycE which was exclusively synthesised during the period of hormone induction. We thus infected these cells with the pBabe puro retrovirus (Morgenstern and Land, 1990a) encoding MycER TM (Littlewood et al., 1995) or the empty control virus and selcted polyclonal populations of the infected cells as well as several MycER TM infected clones. As expected, only the cells in which MycER TM was activated with OHT were stimulated to enter the cell cycle in the absence of mitogens (Figure 5a ). To investigate the status of hCycE/Cdk2 complexes polyclonal pools expressing either hCycE alone or hCycE together with MycER TM as well as two cell clones expressing both proteins were analysed 6 h after exposure to OHT. While the same amount of hCycE was expressed under all conditions (Figure 5b ), high levels of hCycE-speci®c kinase activity were only detectable in cells expressing active MycER TM (Figure 5c ). In the absence of active Myc, Cdk2 and p27
Kip1 associate with the newly synthesised hCycE (Figure 5d ). Moreover, Cdk2 bound to this complex is predominantly in its non-CAK-phosphorylated inactive form (upper band; Figure 5d , top panel). In contrast, hCycE complexes immunoprecipitated from cells in which Myc had been activated contain only little p27 Kip1 ( Figure 5d , bottom panel). In addition, the associated Cdk2 appears to be predominantly in its active CAK-phosphorylated form (lower band; Figure 5d , top panel). Such alterations can only be observed when analysing CycE molecules newly synthesised in the presence of active Myc but not when examining the bulk of cellular CycE (see Figure 1b) . Thus, because of the dierent behaviour of resident and newly formed CycE complexes in response to Myc activation and the concomitant Myc-induced accumulation of cyclin E mRNA, the initial Myc-dependent increase in CycE/Cdk2 kinase activity may involve at least two steps: the stimulation of CycE/Cdk2 complex formation by inducing cyclin E gene transcription and the loss of p27
Kip1 binding to the newly formed complexes. Moreover, the latter also appears to permit an increased rate of CAK-dependent phosphorylation of Cdk2. This is consistent with the capability of p27 Kip1 to physically interfere with CAK-induced activation of Cdk2 and Cdk4 (Kato et al., 1994; Polyak et al., 1994b) .
Myc prevents association of p27
Kip1 with CycE/Cdk2 complexes The decreased binding of p27
Kip1 to newly synthesised CycE/Cdk2 may be due to a Myc-dependent modification of the CycE/Cdk2 complexes or to an alteration in the binding properties of p27 Kip1 . Therefore we challenged active CycE-dependent kinase complexes from proliferating cells or from cells expressing activated MycER (in the absence of mitogens) with boiled Rat1 cell extracts in which p27
Kip1 is released from intra-cellular complexes (Hengst et al., 1994; Polyak et al., 1994a) . In both cases CycE/Cdk2 activity was completely inhibited (not shown), indicating that Myc-induced CycE/Cdk2 complexes are not resistant to inhibition by p27 Kip1 . Next we wanted to test whether the ability of p27
Kip1 to bind to CycE/Cdk2 is regulated by Myc. For this purpose we prepared native extracts from MycER cells at various times after OHT application, since in such extracts p27
Kip 1 activity appears to re¯ect only the pool of non-complexed freely available p27 Kip1 . These extracts were used to challenge a target extract from proliferating E6 cells expressing hCycE-dependent kinase activity. The extract from cells in which MycER is inactive inhibits hCycE/Cdk2 activity two-fold. However, upon activation of Myc this inhibitory activity diminishes to become undetectable after 10 h (Figure 6a , top panel and 6c). This regulation correlates with decreasing amounts of p27 Kip1 entering hCycE/Cdk2 complexes after MycER cell extracts are added (Figure 6a , bottom panel). At the same time the overall levels of p27
Kip1 in the MycER cell extracts remain constant (Figure 6b ). To determine if p27
Kip1 is responsible for the inhibitory activity in native extracts from arrested MycER cells we immunodepleted p27
Kip1 from such extracts before mixing with the target extract ( Figure  6d) . Indeed, the p27 Kip1 -depleted extract is unable to inhibit hCycE/Cdk2 activity of the target extract (Figure 6d) , while a control extract depleted with normal rabbit serum inhibits the kinase activity to a similar extent as non-treated extract (Figure 6d and a) . Thus Myc inhibits the ability of p27
Kip1 to bind to CycE/Cdk2 complexes.
Discussion
Mechanism of CycE/Cdk2 activtion by Myc
We have analysed CycE/Cdk2 activation by Myc during the early phase of kinase induction. At most 10% of the CycE/Cdk2 complexes contribute to the induction of kinase activity when 60% of maximal kinase activity is observed 4 h after Myc activation. During this time, the bulk of CycE/Cdk2 complexes remains bound to p27 Kip1 and inactive. Steiner et al. (1995) reported that Myc-induced activation of CycE/ Cdk2 activity correlates with the breakdown of large preexisting complexes containing CycE and Cdk2 and proposed that this breakdown may be due to a release of p27 Kip1 from such complexes. There is recent evidence that the release of p27
Kip1 from inactive CycE/Cdk2/p27 Kip1 complexes is achieved via phosphorylation of p27
Kip1 by active CycE/Cdk2 at Thr 187 which also earmarks the Cdk inhibitor for ubiquitindirected degradation (J Roberts; B Amati personal communications; Pagano et al., 1995) . Such a positive feed-back mechanism however requires the availability of an active CycE/Cdk2 fraction in order to start this process.
We show that Myc stimulates cyclin E gene transcription followed by rapid protein synthesisindependent three to fourfold accumulation of cyclin E mRNA and an inhibition of p27
Kip1 association with newly formed CycE/Cdk2 complexes. As a consequence this small fraction of complexes undergoes accelerated CAK phosphorylation and kinase activation. Although we don't know whether the induction of cyclin E transcription is a prerequisite for this activation, it is likely that the highly increased mRNA concentration contributes signi®cantly to elevate the pool of activatable CycE/Cdk2 complexes. Our data are thus consistent with a model (Figure 7) Kip1 (bottom panel). In b, c and d cells were treated with OHT for 6 h before being harvested and anlaysed. E6MTR P is a polyclonal population of E6 cells infected with the retrovirus pBabe puro MycER TM ; E6MTR 19 and EtMTR 21 are two independent clones derived from E6MTR P; E6B is a polyclonal population of E6 cells infected with the empty pBabe puro vector. The arrows in d indicate the positions of the bands corresponding to the non-CAK-phosphorylated (upper band) and CAK-phosphorylated (lower band) forms of Cdk2 (Gu et al., 1992) p27
Kip1 complexes through phosphorylation and release of p27 Kip1 . However, for at least 8 h we are unable to detect any alteration in the overall levels of p27
Kip1 as well as its levels in CycE/Cdk2 complexes. Thus, the release of p27
Kip1 from preexisting complexes may play a role during later phases of kinase induction and serve to maintain high levels of CycE/Cdk2 activity for prolonged periods. This may be important, since active CycE/Cdk2 complexes have a shorter half-life than their inactive counterparts (Clurman et al., 1996) . The short half-life of active CycE/Cdk2 complexes may at least in part account for the dierence between the three-to fourfold induction of cyclin E mRNA expression and the small induction of endogenous Cyclin E protein observed in our experiments.
The role of Myc-dependent inhibition of p27
Kip1
The Myc-dependent inhibition of p27
Kip1 binding to the newly synthesised complexes appears to play an important role for kinase activation, as the induction of cyclin E mRNA is not sucient to induce CycE/ Cdk2 kinase activity in the absence of serum factors. In con¯uent mitogen-free cultures newly synthesised CycE associates with non-CAK-phosphorylated, inactive Cdk2 and p27
Kip1 indicating that p27 Kip1 is in excess over CycE/Cdk2 complexes. Moreover, all CycE/Cdk2 complexes bound to p27
Kip1 are inactive. In contrast, Myc activation inhibits p27
Kip1 binding to complexes containing newly synthesised hCycE, a process which follows Myc-activation with similar kinetics as the accumulation of cyclin E mRNA. Moreover parallel experiments by Vlach et al. (1996) show that Myc can rescue a growth arrest induced by p27 Kip1 overexpression. Similarly, a p21
Cip1 -dependent growth arrest in response to Raf activation can be blocked by Myc in murine ®broblasts (AS and HL in preparation). Thus, the ability of Myc to override cell cycle inhibitors such as p27 Kip1 and p21 Cip1 appears to be a major aspect of its function.
Our results are consistent with the idea that the inhibition of p27
Kip1 association may involve sequestration of non-complexed p27
Kip1 by a Myc-induced factor (Vlach et al., 1996) , as during the time course of our experiments the overall concentration of p27 Kip1 remains constant. However, since we are unable to were then mixed with the target extract (T) and hCycE-dependent histone H1 kinase activity was determined as described above (bottom panel) Figure 7 Model of CycE/Cdk2 activation by Myc. Myc stimulates cyclin E gene transcription, therefore allowing increased synthesis of Cyclin E protein. At the same time Myc also inhibits the binding of p27
Kip1 to newly formed CycE/Cdk2 complexes which undergo accelerated CAK phosphorylation and kinase activation. Subsequently active complexes phosphorylate p27
Kip1 in inactive preexisting complexes to further stimulate CycE/Cdk2 kinase activity, while phosphorylated p27
Kip1 is degraded following ubiquitination biochemically distinguish between free and complexed p27 Kip1 , alternative mechanisms of regulation such as post-transitional modi®cation of free p27
Kip1 cannot be excluded.
Involvement of Myc-induced transcription
Since the Cdk2 phosphatase gene cdc25A has been reported to be a Myc target (Galaktionov et al., 1996) , we also tested the induction of cdc25A mRNA by Myc in our cell system. However, compared to the Mycdependent inductions of cyclin E mRNA and CycE/ Cdk2 activity the response of cdc25A mRNA levels is small and slow. While after 4 h of MycER induction cyclin E mRNA is induced to 75% and CycE/Cdk2 activity to approximately 60%, the levels of cdc25A mRNA are not signi®cantly elevated at this time. Moreover, an increase in Cdc25A protein levels cannot be detected. Thus although we cannot exclude some contribution of Cdc25A in regulating CycE/Cdk2 activity, we have no evidence to suggest a major role of Cdc25A in the initial induction of CycE/Cdk2 kinase activity following Myc activation. The observations that CycE-dependent Cdk2 activity immunoprecipitated from cells with active Myc can be super-induced by Cdc25A in vitro (Steiner et al., 1995) and that overexpression of Cdc25A does not rescue a p27
Kip1
-induced growth arrest (Vlach et al., 1996) support this view.
Myc activates cyclin E gene transcription and leads to an accumulation of cyclin E mRNA independent of protein synthesis. However, no high anity Myc consensus DNA binding sites have been found in either the human (Geng et al., 1996) or the murine (Botz et al., 1996) cyclin E genes. Instead cyclin E gene transcription appears to be under control of E2F family transcription factors (Botz et al., 1996; DeGregori et al., 1995; Geng et al., 1996) . Whether there may be a link between E2F and Myc-dependent regulation or whether Myc can induce cyclin E gene transcription in an E2F-independent manner will be interesting to explore.
Materials and methods
Cell culture
Rat1 ®broblasts expressing steroid hormone-inducible fusion proteins of the human c-Myc protein and the hormone binding domain of the oestrogen receptor, MycER (Eilers et al., 1989) or MycER TM (Littlewood et al., 1995) and the chimeric transcription factor GalER-VP16 (Braselmann et al., 1993) were cultivated in phenol red-free Dulbecco's modiifed Eagle's medium supplmented with 10% charcoal-stripped foetal calf serum (FCS). Before induction of the chimeric proteins with 200 nM of 4-hydroxytamoxifen (OHT) the cells were grown to conuence and kept in serum-free medium in the presence of 5 mg/ml of insulin for 48 h.
Rat1 cells expressing OHT-inducible Cyclin E
Rat1 cells expressing the chimeric transcription factor GalER-VP16 (Braselmann et al., 1993) were generated via retroviral infection. Subsequently these cells were transfected with a vector, pGC-HE, containing the human cycE cDNA derived from pCycE/L UHG under the control of a GAL4-dependent promoter (Braselmann et al., 1993) . The plasmid pJ6-hygro (Morgenstern and Land, 1990b) was co-transfected with pGC-HE in a molar ratio of 1 : 10 and colonies resistant to 100 mg/ml of Hygromycin B (Calbiochem) were isolated. To generate cells expressing inducible hCycE together with OHT-dependent Myc the clone E6 was infected with the retrovirus pBabepuro MycER TM (Littlewood et al., 1995) . Colonies resistant to 5 mg/ml puromycin (Sigma) were pooled (E6MTR P) or isolated as single cell clones (E6MTR 19 and E6MTR 21) . A polyclonal population of E6 cells infected with the empty pBabepuro virus and selected under the same conditions served as a control (E6B).
FACS analysis
For cell cycle analysis, quiescent cells were stimulated with OHT and 20 h later were trypsinised and ®xed in 70% ethanol, stained with propidium iodide (10 mg/ml) and analysed with a Becton Dickinson FACScan.
Immunoblotting, immunoprecipitation and kinase activity
Cells were lysed in 50 mM Tris-HCl, ph 8, 150 mM NaCl, 1% Triton, 1 mM DTT, 10 mM NaF 0.5 mM Na 3 VO 4 , 18 mg/ml Aprotinin and 100 mg/ml PMSF. Cellular debris was removed by sedimentation and protein concentration was determined using the BioRad DC protein assay. Cellular proteins (10 to 30 mg) were resolved by SDS ± PAGE, transferred onto Immobilon P membranes (Millipore) with a Genie Blot II (Idea Sci.), blocked with PBS, 0.1% Tween 20 and 5% skimmed milk powder and probed with the following rabbit polyclonal antibodies (from Santa Cruz Biotechnology): rat CycE, M-20 (sc-481), human CycE, C-19 (sc-198) , p27
Kip1 , C-19 (sc-528), Cdk2, M2 (sc-163) and Cdc25A, 144 (sc-097). Filters were washed three times for 10 min in PBS, 0.1% Tween 20. Proteins were detected using horseradish peroxidase conjugated secondary antibodies (goat anti-rabbit IgG Fc, Pierce) and visualized using the enhanced chemiluminescence system (Amersham). For immunoprecipitations, 200 mg of protein were incubated with 1 mg of the appropriate antibody and Protein A-Sepharose beads (4 Fast Flow from Pharmacia Biotech.) for 2 h at 48C, washed four times with lysis buer and resolved by SDS ± PAGE followed by immunoblot analysis. For kinase assays, immunoprecipitates were washed twice more with kinase buer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 1 mM DTT) and reactions were performed in 30 ml of kinase buer containing 15 mg Histone HI, 30 mM ATP and 3 mCi [g-32 P]ATP (Amersham), for 20 min at 308C. Radiolabelled Histone HI was resolved by SDS ± PAGE and quanti®ed with a phosphorimager. For the experiment described in Figure 6 , proliferating E6 cells were treated with OHT for 12 h before they were harvested in lysis buer. From these extracts hCycE-dependent kinase activity can be immunoprecipitated using hCycE-speci®c antibodies. 200 mg of protein from this extract was combined with 300 mg of protein from native extracts from Rat1 MycER cells which had been rendered quiescent and then treated with OHT for various times. The mixed extracts were incubated for 20 min at 308C. Then hCycE complexes were immunoprecipitated with speci®c antibodies and analysed for kinase activity and composition as described above.
RT ± PCR
Total cellular RNA was prepared according to (Belyavsky et al., 1989) with slight modi®cations: cells were lysed in 400 ml of G-CN solution (for a 10 cm petri dish of con¯uent cells). After vortexing thoroughly, 37.5 ml of 1 M NaAcetate (pH 4.0) and 800 ml of phenol : chloroform (5 : 1) were added and the mixture was incubated on ice for 10 min. After centrifugation (20 min at 48C), the RNA was precipitated with 2.7 volumes of ethanol, washed with 70% ethanol, air dried and resuspended in water. cDNA was synthesised using Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV RT, BRL) in the buer provided by the manufacturer in a ®nal volume of 22 ml at 378C for 1 h in the presence of 1 mg of oligo d(T) 12 ± 18 (Pharmacia Biotech.), 1 mM each dNTP (Pharmacia Biotech) and 1 ml of RNasin (Promega), with 2 mg of denatured RNA as template. The cDNA was then used as template for PCR ampli®cation using native Pfu DNA polymerase and the buer provided by the manufacturer (Stratagene) in a ®nal volume of 50 ml containing 200 mM each dNTP, 0.5 mg of each primer and 3 mCi of [a-32 P]dCTP (Amersham). Denaturation, annealing and extension steps were at 948C, 528C and 728C, respectively, for 1 min each. The number of cycles was 18, 22 and 26 to ensure that the reaction had not reached saturation. The primers used were: GAPDH 5', C G T C T T C A C C A C C A T G G A G A , G A P D G 3 ' , CGGCCATCACGCCACAGTTT, CycE 5', GAGGTCTG-GAGGATCATGTT, CycE 3', CTGCATCAACTCCAAC-GAGG, Cdc25A 5', CCAGTGAAGGCAGATGTTCC, Cdc25A 3', TCATTGCCAAGCCTATCTCG.
The ampli®ed products were resolved on a native 4% polycarilamide gel in TBE buer and quanti®ed using a phosphorimager.
Nuclear run-on analysis and hybridisation probes
Preparation of nuclei, elongation reaction, RNA isolation, hybridisation and ®lter washes were carried out exactly as described by Roberts and Bentley (1992) . All probes were isolated cDNA fragments. They were denatured and 1 mg/ slot was blotted onto Genescreen (Dupont). The DNA was cross-linked to the ®lter by exposure to u.v. light for 2 min. Cyclin E cDNA was derived as a 1.25 kb XbaI/SacII fragment from pGEX 3XP . Cyclin A cDNA was isolated as a 1.5 kb EcoRI fragment (lacking 3' untranslated sequences) from pBJ4cycA and was originally derived from pCyc A (Pines and Hunter, 1990) . GAPDH cDNA was prepared as a 1.5 kb EcoRI fragment from PRLC GAP (Tso et al., 1985) .
Northern analysis
Poly(A) + RNA was prepared using the`Fast Track' protocol according to the manufacturer's instructions (Invitrogen). For Northern analysis the RNA was electrophoresed through a 0.8% agarose-formaldehyde gel. The RNA was transferred to a HybondN + membrane (Amersham) and hybridised in QuickHyb according to the manufacturer's instructions (Stratagene). Probes were labelled with [a-32 P]dCTP by random priming of the same cyclin E and GAPDH cDNA fragments described above.
